XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Operating activities:    
Net income $ 24,012 $ 15,065
Adjustments to reconcile net income to net cash used in operating activities:    
(Income) loss from discontinued operations, net of taxes (450) 12,805
Loss on disposal of discontinued operations, net of taxes 1,988 2,262
Equity in net loss (income) of limited liability investments 44 (293)
Depreciation and amortization expense 6,220 6,449
Stock-based compensation expense 1,639 4,052
Net realized gains (761) (1,209)
Net (gain) loss on equity investments (3,397) 26
(Gain) loss on change in fair value of limited liability investments, at fair value (78) 1,754
Net change in unrealized gain on private company investments (63) 0
Gain on change in fair value of real estate investments 0 (1,488)
Loss on change in fair value of debt 68 4,908
Loss (gain) on change in fair value of derivatives 1,643 (17,070)
Loss on change in fair value of contingent consideration 262 1,510
Deferred income taxes, adjusted for SPI and DDI liabilities assumed in 2023 (1,924) 1,406
Impairment losses 229 (0)
Amortization of fixed maturities premiums and discounts 19 236
Gain on disposal of subsidiary (342) (37,917)
Gain on extinguishment of debt (31,616) 0
Changes in operating assets and liabilities:    
Service fee receivable, net, adjusted for SPI and DDI (2023) and CSuite and SNS (2022) acquired 1,123 (136)
Other receivables, net, adjusted for CSuite assets acquired in 2022 2,546 (7)
Deferred contract costs (477) (2,327)
Other assets, adjusted for SPI and DDI (2023) and CSuite and SNS (2022) assets acquired 945 (2,067)
Deferred service fees, adjusted for SPI liabilities assumed in 2023 859 (6,504)
Other, net, adjusted for SPI and DDI (2023) and CSuite and SNS (2022) assets acquired and liabilities assumed (29,338) 15,916
Cash used in operating activities - continuing operations (26,849) (2,629)
Cash provided by (used in) operating activities - discontinued operations 663 (11,945)
Net cash used in operating activities (26,186) (14,574)
Investing activities:    
Proceeds from sales and maturities of fixed maturities 8,468 9,714
Proceeds from sales of equity investments 3,471 0
Purchases of fixed maturities (6,467) (14,211)
Net proceeds from limited liability investments 314 1,577
Net proceeds from limited liability investments, at fair value 14,123 621
Net proceeds from investments in private companies 39 258
Proceeds from sale of real estate investments 0 12,150
Net proceeds from other investments and short-term investments 16 55
Net proceeds from disposal of subsidiary, net of cash disposed of $1,391 342 35,158
Acquisition of businesses, net of cash acquired (13,633) (13,689)
Net (purchases) disposals of property and equipment, adjusted for DDI assets acquired in 2023 (205) 26,461
Cash provided by investing activities - continuing operations 6,468 58,094
Cash (used in) provided by investing activities - discontinued operations (11) 42,846
Net cash provided by investing activities 6,457 100,940
Financing activities:    
Proceeds from exercise of warrants 16,658 545
Cash paid for repurchase of warrants (4,031) 0
Cash paid for repurchase of common stock (3,204) 0
Distributions to noncontrolling interest holders (4,018) (6,016)
Payment of contingent consideration from acquisition (375) (750)
Taxes paid related to net share settlements of restricted stock awards (450) (396)
Principal proceeds from bank loans, net of debt issuance costs of $68 in 2023 and $167 in 2022 5,533 12,682
Principal payments on bank loans (9,113) (5,228)
Purchase of subordinated debt (40,328) 0
Payment of debt issuance costs (25) 0
Principal payments on notes payable 0 (6,411)
Cash used in financing activities - continuing operations (39,353) (5,574)
Cash used in financing activities - discontinued operations (610) (32,358)
Net cash used in financing activities (39,963) (37,932)
Net (decrease) increase in cash and cash equivalents and restricted cash from continuing operations (59,734) 49,891
Cash and cash equivalents and restricted cash at beginning of period 77,802 29,899
Less: cash and cash equivalents and restricted cash of discontinued operations 570 2,558
Cash and cash equivalents and restricted cash of continuing operations at beginning of period 77,232 27,341
Cash and cash equivalents and restricted cash of continuing operations at end of period 17,498 77,232
Supplemental disclosures of cash flows information:    
Interest 24,581 1,427
Income taxes 1,894 501
Non-cash investing and financing activities from continuing operations:    
Conversion of Stock, Amount Issued 6,086 788
Accrued dividends on Class A preferred stock issued $ 74 $ 306